DECEMBER 21, 2017

Company

GYRE THERAPEUTICS, INC.

Filed

December 27, 2017

Accession Number

0001013594-17-000844

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →